EUVIMEDEUVIMED entdecken
Crossref

TXD‐198 Exhibits Inhibitory Activity Against SARS‐CoV‐2 by Upregulating ANO1

Ruilin Chen, Weiya Kong, Chengyu Li, Jing Zhang, Dan Guo, Shuwen Liu iD, Xiaodong Tang, Xingang Yao iD

Journal of Medical Virology · 2026-06 · 98 (6)

DOI: 10.1002/jmv.71004 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medical Virology, online erschienen am 10.06.2026. Verfasst von Ruilin Chen und 7 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Organ Failure Research, Guangdong Provincial Key Laboratory of New Drug Screening, School of Pharmaceutical Sciences, Souther…. Hauptthemen laut MEDLINE: SARS-CoV-2, Antiviral Agents, Anoctamin-1, COVID-19 Drug Treatment. Die Arbeit nennt 40 Literaturangaben. Gefördert von: Special Project for Research and Development in Key areas of Guangdong Province, Prevention and Control of Emerging and Major Infectious Diseases - National Science and Technology Major Project, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The continuous global health challenge posed by the novel coronavirus SARS‐CoV‐2 emphasizes the urgent demand for effective antiviral therapies. This study discovers TXD‐198 as a potent inhibitor of SARS‐CoV‐2 infection. Through a transcription‐ and replication‐competent virus‐like particle (trVLP) system, it's shown that TXD‐198 efficiently suppresses viral activity with an IC 50 of 1.04 μM and a high selectivity index of 42.55. Validation in two distinct pseudoviral models‐the replication‐competent rVSV‐Venus‐VSV∆G‐SARS2‐S∆21 system and SARS‐CoV‐2 spike‐pseudotyped lentiviral system (PSVs) further confirmed TXD‐198's antiviral ability. Transcriptomic analysis reveals that TXD‐198 exerts antiviral effects through a dual mechanism of direct viral inhibition and anti‐inflammatory activity. Notably, TXD‐198 significantly upregulates the expression of the ANO1 gene, and knocking down ANO1 reverses the antiviral effect of TXD‐198, indicating ANO1's crucial role in TXD‐198's antiviral action. These findings suggest TXD‐198 is a promising therapeutic candidate for COVID‐19 treatment related to ANO1, calling for further exploration of its clinical potential.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SARS-CoV-2Antiviral AgentsAnoctamin-1COVID-19 Drug TreatmentHumansUp-RegulationVirus ReplicationAnimalsHEK293 CellsSpike Glycoprotein, CoronavirusVero CellsCOVID-19

Stichwörter der Autor:innen

SARS‐CoV‐2antiviral drugsdrug screeningspike

Substanzen

Antiviral AgentsAnoctamin-1Spike Glycoprotein, Coronavirus

Autor:innen und Institutionen

  • State Key Laboratory of Organ Failure Research, Guangdong Provincial Key Laboratory of New Drug Screening, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou, P. R. China.
  • Key Laboratory of Infectious Diseases Research in South China (Southern Medical University), Ministry of Education, Guangzhou, China.

ORCID-Profile: Shuwen Liu, Xingang Yao

Förderung

  • Special Project for Research and Development in Key areas of Guangdong Province
  • Prevention and Control of Emerging and Major Infectious Diseases - National Science and Technology Major Project
  • National Natural Science Foundation of China
  • Post Scientist Fund awarded by Chinese Academy of Traditional Chinese Medicine

Zitieren

APA

Chen, R., Kong, W., Li, C., Zhang, J., Guo, D., Liu, S., Tang, X., & Yao, X. (2026). TXD‐198 Exhibits Inhibitory Activity Against SARS‐CoV‐2 by Upregulating ANO1. Journal of Medical Virology, 98(6). https://doi.org/10.1002/jmv.71004

Vancouver

Chen R, Kong W, Li C, Zhang J, Guo D, Liu S, et al. TXD‐198 Exhibits Inhibitory Activity Against SARS‐CoV‐2 by Upregulating ANO1. Journal of Medical Virology. 2026;98(6). doi:10.1002/jmv.71004

BibTeX
@article{Chen2026,
  author = {Chen, Ruilin and Kong, Weiya and Li, Chengyu and Zhang, Jing and Guo, Dan and Liu, Shuwen and Tang, Xiaodong and Yao, Xingang},
  title = {TXD‐198 Exhibits Inhibitory Activity Against SARS‐CoV‐2 by Upregulating ANO1},
  journal = {Journal of Medical Virology},
  year = {2026},
  volume = {98},
  number = {6},
  doi = {10.1002/jmv.71004}
}
Kostenlos starten →